14.88
0.53 (3.69%)
| Penutupan Terdahulu | 14.35 |
| Buka | 14.68 |
| Jumlah Dagangan | 294,162 |
| Purata Dagangan (3B) | 1,701,213 |
| Modal Pasaran | 2,481,820,160 |
| Harga / Pendapatan (P/E TTM) | 10.94 |
| Harga / Pendapatan (P/E Ke hadapan) | 42.02 |
| Harga / Jualan (P/S) | 2.49 |
| Harga / Buku (P/B) | 3.27 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 May 2025 - 12 May 2025 |
| Margin Keuntungan | 23.64% |
| Margin Operasi (TTM) | 2.69% |
| EPS Cair (TTM) | 1.36 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 12.40% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 213.90% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 7.10% |
| Nisbah Semasa (MRQ) | 2.38 |
| Aliran Tunai Operasi (OCF TTM) | 157.72 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 270.08 M |
| Pulangan Atas Aset (ROA TTM) | 5.44% |
| Pulangan Atas Ekuiti (ROE TTM) | 38.89% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menurun |
| Biotechnology (Global) | Bercampur | Menurun | |
| Stok | ACADIA Pharmaceuticals Inc. | Menaik | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | -1.5 |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.0 |
| Purata | 0.40 |
|
Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 0.46% |
| % Dimiliki oleh Institusi | 101.20% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 28.00 (Needham, 88.17%) | Beli |
| 28.00 (Cantor Fitzgerald, 88.17%) | Beli | |
| Median | 27.00 (81.45%) | |
| Rendah | 20.00 (Morgan Stanley, 34.41%) | Pegang |
| Purata | 25.00 (68.01%) | |
| Jumlah | 4 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 17.00 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| UBS | 28 Apr 2025 | 22.00 (47.85%) | Beli | 14.66 |
| Needham | 08 Apr 2025 | 28.00 (88.17%) | Beli | 14.10 |
| 27 Feb 2025 | 28.00 (88.17%) | Beli | 19.34 | |
| Morgan Stanley | 07 Mar 2025 | 20.00 (34.41%) | Pegang | 17.56 |
| Cantor Fitzgerald | 27 Feb 2025 | 28.00 (88.17%) | Beli | 19.34 |
| HC Wainwright & Co. | 27 Feb 2025 | 27.00 (81.45%) | Beli | 19.34 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| KIHARA JAMES | - | 14.91 | -1,327 | -19,786 |
| SCHNEYER MARK C. | - | 14.91 | -3,498 | -52,155 |
| Jumlah Keseluruhan Kuantiti Bersih | -4,825 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -71,941 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 14.91 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| SCHNEYER MARK C. | Pegawai | 02 May 2025 | Jual automatik (-) | 3,498 | 14.91 | 52,155 |
| KIHARA JAMES | Pegawai | 02 May 2025 | Jual automatik (-) | 1,327 | 14.91 | 19,786 |
| SCHNEYER MARK C. | Pegawai | 01 May 2025 | Pelaksanaan pilihan | 6,815 | - | - |
| KIHARA JAMES | Pegawai | 01 May 2025 | Pelaksanaan pilihan | 2,596 | - | - |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |